Core Viewpoint - The company has received high-tech enterprise certification for multiple subsidiaries, which will allow them to benefit from preferential tax policies for the next three years [1][2]. Group 1: Certification Details - The company's subsidiary, Xuancheng Meinuohua Pharmaceutical Co., Ltd., received a high-tech enterprise certificate from the Anhui Provincial Department of Industry and Information Technology, with a certificate number GR202534001271, issued on October 28, 2025, valid for three years [1]. - The wholly-owned subsidiary, Ningbo High-tech Zone Meinuohua Pharmaceutical Innovation Research Institute Co., Ltd., received a high-tech enterprise certificate from the Ningbo Science and Technology Bureau, with a certificate number GR202533101572, issued on December 26, 2025, valid for three years [1]. - Another wholly-owned subsidiary, Ningbo Meinuohua Tiankang Pharmaceutical Co., Ltd., also received a high-tech enterprise certificate from the Ningbo Science and Technology Bureau, with a certificate number GR202533102561, issued on December 26, 2025, valid for three years [1]. Group 2: Tax Benefits - Following the certification, Xuancheng Meinuohua, the Innovation Research Institute, and Meinuohua Tiankang will enjoy national preferential policies for high-tech enterprises, allowing them to pay a corporate income tax rate of 15% for the years 2025, 2026, and 2027 [2].
美诺华(603538.SH):子公司通过高新技术企业重新认定